ArticleAntimicrobial agents and chemotherapy1999

In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.

J K Akada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.